Discovery and preliminary characterization of novel tyrosine kinase inhibitors with to BTK

被引：0

作者：

Namdev, Nivedita D. ^{[1
]}

Cornell-Kennon, Susan ^{[1
]}

Yu, Yi ^{[1
]}

Hill, Jason ^{[1
]}

Bull, Cathy ^{[1
]}

Volak, Laurie ^{[1
]}

Wang, Jianqiang ^{[1
]}

Lowe, Deirdre ^{[1
]}

Gu, Xuibin ^{[1
]}

Koerner, Steffi ^{[1
]}

Moussa, Magdi ^{[1
]}

Vensel, David ^{[1
]}

Liu, Yanbin ^{[1
]}

Wu, Hui ^{[1
]}

Chen, Chang-Rung ^{[1
]}

Dransfield, Daniel T. ^{[1
]}

Ashwell, Mark A. ^{[1
]}

机构：

[1] ArQule Inc, Woburn, MA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期

关键词：

D O I：

10.1158/1535-7163.TARG-13-B270

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B270

引用

页数：1

共 50 条

[21] Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Weisberg, Ellen
Choi, Hwan Geun
Barrett, Rosemary
Zhou, Wenjun
Zhang, Jianming
Ray, Arghya
Nelson, Erik A.
Jiang, Jingrui
Moreno, Daisy
Stone, Richard
Galinsky, Ilene
Fox, Edward
Adamia, Sophia
Kung, Andrew L.
Gray, Nathanael S.
Griffin, James D.
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2468 - 2477
[22] XLA - Studies on the Btk tyrosine kinase
Smaith, CIE
Backesjo, CM
Branden, LJ
Islam, T
Mattsson, PT
Mohamed, AJ
Nore, BF
Vargas, L
Vihinen, M
MOLECULAR IMMUNOLOGY, 1998, 35 (11-12) : 669 - 670
[23] Discovery of novel inhibitors of tyrosine kinases.
Webb, TR
Lvovskiy, D
Heinrich, MC
Yee, JWH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U40 - U40
[24] Discovery and development of covalent BTK inhibitors
Chen, Wei
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
[25] Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases
Shi, Qing
Tebben, Andrew
Dyckman, Alaric J.
Li, Hedy
Liu, Chunjian
Lin, James
Spergel, Steve
Burke, James R.
McIntyre, Kim W.
Olini, Gilbert C.
Strnad, Joann
Surti, Neha
Muckelbauer, Jodi K.
Chang, Chiehying
An, Yongmi
Cheng, Lin
Ruan, Qian
Leftheris, Katerina
Carter, Percy H.
Tino, Joseph
De Lucca, George V.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2206 - 2211
[26] Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation
Narayanan, Ramesh
Yepuru, Muralimohan
Coss, Christopher C.
Wu, Zhongzhi
Bauler, Matthew N.
Barrett, Christina M.
Mohler, Michael L.
Wang, Yun
Kim, Juhyun
Snyder, Linda M.
He, Yali
Levy, Nelson
Miller, Duane D.
Dalton, James T.
PLOS ONE, 2013, 8 (12):
[27] Discovery of pyrido[3,4-b]indol-1-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors
Dou, Dou
Sha, Wenjie
Diao, Yanyan
Su, Rongrong
Qiao, Yunjin
Yu, Zhixiao
Zhao, Zhenjiang
Li, Honglin
Chen, Zhuo
Xu, Yufang
BIOORGANIC CHEMISTRY, 2022, 119
[28] Discovery of Pteridine-7(8H)-one Derivatives as Potent and Selective Inhibitors of Bruton's Tyrosine Kinase (BTK)
Dou, Dou
Diao, Yanyan
Sha, Wenjie
Su, Rongrong
Tong, Linjiang
Li, Wenjie
Leng, Limin
Xie, Lijuan
Yu, Zhixiao
Song, Haoming
Shen, Zihao
Zhu, Lili
Zhao, Zhenjiang
Xie, Hua
Chen, Zhuo
Li, Honglin
Xu, Yufang
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (03) : 2694 - 2709
[29] Mutations in the Bruton Tyrosine Kinase (BTK) Gene in Patients with Chronic Lymphocytic Leukemia (CLL) Receiving BTK Inhibitors (BTKis)
Skarbnik, Alan P.
Danilov, Alexey V.
Hoffmann, Marc
Awan, Farrukh T.
Scarpa, Frank
Davies, Caryn
Oakland, Todd
Kovach, Marina
Lilyquist, Jenna
Munugalavadla, Veerendra
Yong, Alan S. M.
Shetty, Vikram
Allan, John N.
Woyach, Jennifer A.
BLOOD, 2024, 144 : 4623 - 4624
[30] Discovery of Tricyclic Pyranochromenone as Novel Bruton's Tyrosine Kinase Inhibitors with In Vivo Antirheumatic Activity
Cho, Hyewon
Lee, Eun
Kwon, Hye Ah
Seul, Lee
Jeon, Hui-Jeon
Yu, Ji Hoon
Ryu, Jae-Ha
Jeon, Raok
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 15

← 1 2 3 4 5 →